The Wyss Center receives ISO 13485 Certification by TÜV SÜD for its Quality Management System

Wyss Center appoints Dr. Craig Cook as new Head of Business Development and Licensing

Wyss Center Geneva appoints Erwin Böttinger as new Chief Executive Officer

The appointment follows a funding commitment of CHF 120 million from the Wyss Foundation to further strengthen the Center’s mission to accelerate innovative therapies to the clinic to transform the lives of people with brain disorders.

New project: STAR - Solutions Through Astrocyte Research

The STAR team is pursuing new strategies, focused on astrocytes, to identify biomarkers and new therapeutic targets to treat neurological and psychiatric disorders.

Brain-computer interfaces: New technology. More data. Improving lives.

Symposium: As the BCI community shifts its focus to clinical studies for patient benefit, join us to hear from researchers and companies working together at the forefront of BCI development discussing paths to translation and BCI home-use.

POSTPONED Event: The gut-brain axis

Join us for a fascinating journey through the gut and brain as we learn more about the enteric nervous system and discover the latest strategies to restore gut function.

Swiss science celebrates Hansjörg Wyss

Today, Hansjörg Wyss received the Gallatin Award from the Swiss American Chamber of Commerce for his great commitments to the science landscape in Switzerland.

Wyss Center announces the appointment of Dr Richie Kohman as Chief Scientific Officer

Dr Kohman brings more than 15 years of research and industry experience in the development of transformative technologies for healthcare and society.

Wyss Center CDO recognized as Alumna of the Year

The Wyss Center’s Chief Development Officer (CDO), Dr Tracy Laabs, has been awarded Pharmacology and Toxicology Alumna of the Year by the University of Wisconsin–Madison, in recognition of her career accomplishments and global impact on research and translation.

Wyss Center appoints Olivier Coquoz as COO

The Wyss Center for Bio and Neuroengineering today announced the promotion of Olivier Coquoz to Chief Operating Officer (COO).